Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
9.02
+2.17 (31.68%)
At close: Mar 9, 2026, 4:00 PM EDT
9.38
+0.36 (3.99%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Cartesian Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -130.3 | -77.42 | -219.71 | 35.38 | -25.69 |
| Depreciation & Amortization | 2.96 | 1.15 | 0.84 | 1.29 | 1.25 |
| Loss (Gain) From Sale of Assets | - | 0.27 | 0.48 | -0.15 | - |
| Asset Writedown & Restructuring Costs | 56.7 | 7.58 | 0.71 | - | - |
| Loss (Gain) From Sale of Investments | 2 | - | -0.08 | -0.38 | 0.06 |
| Stock-Based Compensation | 10.52 | 6.58 | 22.52 | 11.19 | 7.72 |
| Other Operating Activities | -7.76 | 43.96 | 139.1 | -18.59 | 4.47 |
| Change in Accounts Receivable | -0.24 | 7.98 | 0.91 | 0.16 | -2.69 |
| Change in Accounts Payable | 1.07 | -2.93 | 2.83 | 0.09 | -0.22 |
| Change in Unearned Revenue | - | -5.85 | 5.26 | -64.71 | -45.5 |
| Change in Income Taxes | - | - | - | -0.6 | 0.6 |
| Change in Other Net Operating Assets | -8.89 | -4.99 | -4.03 | 4.68 | -0.39 |
| Operating Cash Flow | -73.94 | -23.67 | -51.16 | -31.63 | -60.38 |
| Capital Expenditures | -5.45 | -9.09 | -0.21 | -1.2 | -1.09 |
| Sale of Property, Plant & Equipment | - | 0.35 | - | - | - |
| Cash Acquisitions | - | - | 6.56 | - | - |
| Investment in Securities | - | - | 28.25 | -13.8 | -16.06 |
| Investing Cash Flow | -5.45 | -8.74 | 34.61 | -15 | -17.14 |
| Long-Term Debt Repaid | - | - | -27.46 | - | - |
| Net Debt Issued (Repaid) | - | - | -27.46 | - | - |
| Issuance of Common Stock | 0.32 | 128.49 | 0.23 | 39.33 | 52.9 |
| Other Financing Activities | -8.38 | -0.07 | -6.17 | -0.11 | - |
| Financing Cash Flow | -8.06 | 168.43 | -13.15 | 39.22 | 52.9 |
| Foreign Exchange Rate Adjustments | 0.05 | -0.02 | -0.05 | 0.02 | -0 |
| Net Cash Flow | -87.41 | 135.99 | -29.75 | -7.4 | -24.63 |
| Free Cash Flow | -79.4 | -32.77 | -51.37 | -32.83 | -61.47 |
| Free Cash Flow Margin | -2838.58% | -84.21% | -197.53% | -29.64% | -72.25% |
| Free Cash Flow Per Share | -3.06 | -1.89 | -9.94 | -6.75 | -16.13 |
| Cash Interest Paid | - | - | 1.85 | 2.25 | 2 |
| Levered Free Cash Flow | -55.62 | -59.67 | 28.91 | 22.24 | - |
| Unlevered Free Cash Flow | -55.62 | -59.67 | 30.68 | 24.13 | - |
| Change in Working Capital | -8.06 | -5.79 | 4.97 | -60.38 | -48.19 |
Source: S&P Capital IQ. Standard template.
Financial Sources.